{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:06:06Z","timestamp":1784930766041,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005006","name":"Asan Medical Center Asan Institute for Life Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.breast.2025.104615","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T23:00:48Z","timestamp":1760655648000},"page":"104615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effect of adjuvant endocrine therapy on recurrence and contralateral breast cancer in HR-positive DCIS after mastectomy"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1222-594X","authenticated-orcid":false,"given":"Tae-in","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4989-1636","authenticated-orcid":false,"given":"Ah Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il Yong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Seok","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Ho","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jin","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Eon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonghan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1678-3364","authenticated-orcid":false,"given":"Woong Ki","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"On Vox","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai Min","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3370-6937","authenticated-orcid":false,"given":"Sae Byul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.breast.2025.104615_bib1","first-page":"256","article-title":"Standard for the management of ductal carcinoma in situ of the breast (DCIS)","volume":"52","author":"Morrow","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.breast.2025.104615_bib2","article-title":"NCCN clinical practice guidelines in oncology","year":"2024","journal-title":"Breast Cancer"},{"issue":"5","key":"10.1016\/j.breast.2025.104615_bib3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.amjsurg.2023.07.012","article-title":"Mastectomy margins for ductal carcinoma-in-situ (DCIS): 18 years of follow-up","volume":"226","author":"ElSherif","year":"2023","journal-title":"Am J Surg"},{"issue":"10","key":"10.1016\/j.breast.2025.104615_bib4","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.ejso.2015.07.021","article-title":"Radiotherapy after mastectomy for screen-detected ductal carcinoma in situ","volume":"41","author":"Clements","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.breast.2025.104615_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.clinimag.2021.11.018","article-title":"Contralateral breast cancer after curative-intent treatment for ductal carcinoma in situ: rate and associated clinicopathological and imaging risk factors","volume":"82","author":"Hovis","year":"2022","journal-title":"Clin Imaging"},{"issue":"1","key":"10.1016\/j.breast.2025.104615_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.breast.2025.104615_bib7","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1245\/s10434-017-5931-2","article-title":"Contralateral breast cancer risk in women with ductal carcinoma in situ: is it high enough to justify bilateral mastectomy?","volume":"24","author":"Miller","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.breast.2025.104615_bib8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS","volume":"103","author":"Wapnir","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"9169","key":"10.1016\/j.breast.2025.104615_bib9","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","article-title":"Tamoxifen in treatment of intraductal breast cancer: national surgical adjuvant breast and bowel project B-24 randomised controlled trial","volume":"353","author":"Fisher","year":"1999","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.breast.2025.104615_bib10","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1200\/JCO.2010.34.0141","article-title":"Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24","volume":"30","author":"Allred","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2025.104615_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jjco\/hyae122","article-title":"Update on the management of ductal carcinoma in situ of the breast: current approach and future perspectives","volume":"55","author":"Kanbayashi","year":"2025","journal-title":"Jpn J Clin Oncol"},{"issue":"11","key":"10.1016\/j.breast.2025.104615_bib12","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1245\/s10434-021-09972-2","article-title":"Ductal carcinoma in situ in young women: increasing rates of mastectomy and variability in endocrine therapy use","volume":"28","author":"Byun","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2025.104615_bib13","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83045","article-title":"Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ: retrospective cohort study","volume":"12","author":"Niu","year":"2023","journal-title":"eLife"},{"issue":"3","key":"10.1016\/j.breast.2025.104615_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.amjsurg.2020.11.012","article-title":"Contralateral breast cancer risk and endocrine therapy use in patients with ductal carcinoma in situ treated with unilateral mastectomy in the modern era","volume":"221","author":"ElSherif","year":"2021","journal-title":"Am J Surg"},{"key":"10.1016\/j.breast.2025.104615_bib15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(15)01168-X","article-title":"Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial","volume":"387","author":"Margolese","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2025.104615_bib16","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0140-6736(15)01129-0","article-title":"Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial","volume":"387","author":"Forbes","year":"2016","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.breast.2025.104615_bib17","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1200\/JCO.18.01779","article-title":"Randomized placebo controlled trial of low-dose tamoxifen to prevent local and contralateral recurrence in breast intraepithelial neoplasia","volume":"37","author":"DeCensi","year":"2019","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.breast.2025.104615_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12052036","article-title":"Molecular signatures in ductal carcinoma in situ (DCIS): a systematic review and meta-analysis","volume":"12","author":"Ouattara","year":"2023","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.breast.2025.104615_bib19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jnci\/djt067","article-title":"A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast","volume":"105","author":"Solin","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.breast.2025.104615_bib20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41416-021-01417-7","article-title":"The risk of contralateral breast cancer: a SEER-based analysis","volume":"125","author":"Giannakeas","year":"2021","journal-title":"British journal of cancer"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625006320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625006320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:31:57Z","timestamp":1784928717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977625006320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":20,"alternative-id":["S0960977625006320"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2025.104615","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of adjuvant endocrine therapy on recurrence and contralateral breast cancer in HR-positive DCIS after mastectomy","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2025.104615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104615"}}